CCND2 and leukemia: The molecular mechanisms by which RUNX1/ETO promotes CCND2 expression highlights the complexity of how leukemogenic transcription factors reprogram the epigenome and establish an aberrant transcriptional network essential for leukemia maintenance and self-renewal.